CBT
BMY icon

CoreFirst Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

CoreFirst Bank & Trust’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$307K Hold
5,057
– – 0.16% 98
2025
Q4 		$273K Sell
5,057
-2,210
-30% -$106K 0.15% 102
2025
Q3 		$328K Hold
7,267
– – 0.18% 94
2025
Q2 		$336K Buy
7,267
+610
+9% +$29.9K 0.19% 91
2025
Q1 		$406K Hold
6,657
– – 0.26% 79
2024
Q4 		$377K Sell
6,657
-173
-3% -$9.67K 0.22% 83
2024
Q3 		$353K Sell
6,830
-5,110
-43% -$240K 0.2% 94
2024
Q2 		$496K Sell
11,940
-440
-4% -$19.7K 0.33% 71
2024
Q1 		$671K Hold
12,380
– – 0.42% 57
2023
Q4 		$635K Sell
12,380
-627
-5% -$32.9K 0.42% 60
2023
Q3 		$755K Sell
13,007
-585
-4% -$35.8K 0.54% 46
2023
Q2 		$869K Sell
13,592
-225
-2% -$15.1K 0.61% 38
2023
Q1 		$958K Sell
13,817
-900
-6% -$63.5K 0.7% 36
2022
Q4 		$1.06M Buy
14,717
+800
+6% +$60.3K 0.8% 26
2022
Q3 		$989K Sell
13,917
-2
-0% -$145 0.85% 26
2022
Q2 		$1.07M Buy
13,919
+2,000
+17% +$152K 0.85% 26
2022
Q1 		$871K Hold
11,919
– – 0.6% 43
2021
Q4 		$743K Sell
11,919
-240
-2% -$14.1K 0.48% 50
2021
Q3 		$720K Sell
12,159
-1,807
-13% -$119K 0.5% 46
2021
Q2 		$933K Buy
13,966
+87
+0.6% +$5.67K 0.64% 40
2021
Q1 		$876K Sell
13,879
-400
-3% -$24.9K 0.6% 41
2020
Q4 		$886K Buy
+14,279
New +$878K 0.66% 35

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CoreFirst Bank & Trust's BMY Position: Q1 2026 in Review

CoreFirst Bank & Trust held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 5,057 shares worth $307K. The position accounts for 0.16% of the portfolio, ranked #98.

CoreFirst Bank & Trust first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.07M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • CoreFirst Bank & Trust held 5,057 shares of Bristol-Myers Squibb worth $307K as of Q1 2026.
  • CoreFirst Bank & Trust left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.16% of CoreFirst Bank & Trust's portfolio in Q1 2026, its #98 holding.
  • CoreFirst Bank & Trust first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
  • CoreFirst Bank & Trust's Bristol-Myers Squibb position peaked at $1.07M in Q2 2022.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on CoreFirst Bank & Trust's 13F filing for Q1 2026, filed 3 Jun 2026.